This new model of vaccines is a carefully organized structure that boosts cancer-fighting immunity.

The clinical trial at Mizzou marks the latest human trial involving radioisotopes to treat cancer.

Researchers developed lab-grown human spinal cord organoids to model different types of spinal cord injuries and test new therapy.